Similar articles for PMID: 19180438

Year	Number of Results
1998	1
1999	1
2001	5
2002	7
2003	19
2004	13
2005	17
2006	17
2007	11
2008	27
2009	39
2010	28
2011	31
2012	30
2013	15
2014	22
2015	17
2016	7
2017	1
2018	2
2019	2
2020	2
2024	0

1

[Comment from the cardiologic viewpoint].

Lüscher TF. Lüscher TF. Praxis (Bern 1994). 2009 Feb 4;98(3):129-30. doi: 10.1024/1661-8157.98.3.129. Praxis (Bern 1994). 2009. PMID: 19180438 German. No abstract available.

2

[Comment from the lipidologic viewpoint].

Riesen WF. Riesen WF. Praxis (Bern 1994). 2009 Feb 4;98(3):125-7. doi: 10.1024/1661-8157.98.3.125. Praxis (Bern 1994). 2009. PMID: 19180437 German. No abstract available.

3

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW; STELLAR Study Group. Jones PH, et al. Am J Cardiol. 2003 Jul 15;92(2):152-60. doi: 10.1016/s0002-9149(03)00530-7. Am J Cardiol. 2003. PMID: 12860216 Clinical Trial.

4

[Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].

Karie S, Launay-Vacher V, Deray G, Isnard-Bagnis C. Karie S, et al. Presse Med. 2006 Feb;35(2 Pt 1):219-29. doi: 10.1016/s0755-4982(06)74557-2. Presse Med. 2006. PMID: 16493350 Review. French.

5

Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003.

Shepherd J, Hunninghake DB, Barter P, McKenney JM, Hutchinson HG. Shepherd J, et al. Atheroscler Suppl. 2004 Oct;5(3):115-23. doi: 10.1016/j.atherosclerosissup.2004.08.032. Atheroscler Suppl. 2004. PMID: 15531284 No abstract available.

6

[High lowering of lipids can melt coronary plaques -- is coronary disease reversible?].

Einecke D. Einecke D. MMW Fortschr Med. 2006 Jun 15;148(24):4-5. MMW Fortschr Med. 2006. PMID: 16850796 German. No abstract available.

7

Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.

Shepherd J, Hunninghake DB, Barter P, McKenney JM, Hutchinson HG. Shepherd J, et al. Am J Cardiol. 2003 Mar 6;91(5A):11C-17C; discussion 17C-19C. doi: 10.1016/s0002-9149(03)00004-3. Am J Cardiol. 2003. PMID: 12646338 Clinical Trial.

8

Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.

Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW; Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group. Jones PH, et al. Clin Ther. 2004 Sep;26(9):1388-99. doi: 10.1016/j.clinthera.2004.09.006. Clin Ther. 2004. PMID: 15531001 Clinical Trial.

9

Is rosuvastatin really a more efficient therapeutic option than atorvastatin?

Soto J, Fernandez de Bobadilla J. Soto J, et al. Value Health. 2006 Jul-Aug;9(4):276-7; author reply 277-9. doi: 10.1111/j.1524-4733.2006.00111.x. Value Health. 2006. PMID: 16903999 Free article. No abstract available.

10

From CARDS to AURORA: one disease, two responses.

Escobar C, Barrios V, Echarri R. Escobar C, et al. Hellenic J Cardiol. 2010 May-Jun;51(3):281. Hellenic J Cardiol. 2010. PMID: 20515865 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

291 results

Results by year